Alexander C. Ford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (28)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

NICOLA DE BORTOLI

Associate Professor

University of Pisa

ITALY

View details

Eamonn M. M. Quigley

UNITED STATES

View details

Robert West

Professor of Biostatistics

University of Leeds

UNITED KINGDOM

View details

Nicholas J. Talley

Newcastle University

AUSTRALIA

View details

Edoardo Savarino

Associate Professor

University of Padua

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alexander C. Ford

Research Interests

Explore related searches

Contact this professor

Articles (28)

Common misconceptions and controversies in the management of irritable bowel syndrome

Editorial on ‘Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort’. Authors' Reply

Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort

Management of irritable bowel syndrome in primary care

Network Meta‐Analysis: Efficacy of Biological Therapies and Small Molecules as Maintenance Therapy in Ulcerative Colitis

Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis

Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients’ and GPs’ views and experiences

Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow‐Up

Editorial: Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow‐Up. Authors' Reply

Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target

Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population

Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome

Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis

Concordance between Rome III and Rome IV criteria in irritable bowel syndrome

Efficacy of Drugs Acting on Histamine 1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?

Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden

Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome

Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis

Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 12 months of longitudinal follow‐up

Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis

Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy

Editorial: Recognising the regional variations in profile of irritable bowel syndrome—better late than never! Authors' reply

Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis

A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care

Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome—authors' reply

A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care

Editorial: ondansetron for patients with IBS‐D and bowel‐predominant symptoms—authors' reply

Collaborators (5)

NICOLA DE BORTOLI

Eamonn M. M. Quigley

Robert West

Nicholas J. Talley

Edoardo Savarino

Make your next move.